(Q46687142)

English

Initial experience with bosentan (Tracleer) as treatment for pulmonary arterial hypertension (PAH) due to congenital heart disease in infants and young children

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16142516

Initial experience with bosentan (Tracleer) as treatment for pulmonary arterial hypertension (PAH) due to congenital heart disease in infants and young children (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16142516

congenital heart disease

1 reference

based on heuristic

inferred from title

object named as

F Berger

6

0 references

author name string

N Gilbert

1

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16142516

Y-C Luther

2

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16142516

O Miera

3

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16142516

N Nagdyman

4

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16142516

P Ewert

5

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16142516

P E Lange

7

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16142516

I Schulze-Neick

8

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16142516

publication date

1 September 2005

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16142516

Clinical Research in Cardiology

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16142516

94

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16142516

9

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16142516

570-574

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16142516

Endothelins and endothelin receptor antagonists: therapeutic considerations for a novel class of cardiovascular drugs

1 reference

https://api.crossref.org/works/10.1007%2FS00392-005-0266-6

21 January 2018

Behandlung der Pulmonal Arteriellen Hypertonie

1 reference

https://pubmed.ncbi.nlm.nih.gov/16142516

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Endothelin-receptor antagonist bosentan prevents and reverses hypoxic pulmonary hypertension in rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/16142516

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Grading the severity of congestive heart failure in infants

1 reference

https://pubmed.ncbi.nlm.nih.gov/16142516

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics, safety, and efficacy of bosentan in pediatric patients with pulmonary arterial hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/16142516

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oral sildenafil as long-term adjunct therapy to inhaled iloprost in severe pulmonary arterial hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/16142516

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acute right ventricular failure—from pathophysiology to new treatments

1 reference

https://pubmed.ncbi.nlm.nih.gov/16142516

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

End points in pulmonary arterial hypertension: the way forward

1 reference

https://pubmed.ncbi.nlm.nih.gov/16142516

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term prostacyclin for pulmonary hypertension with associated congenital heart defects

1 reference

https://pubmed.ncbi.nlm.nih.gov/16142516

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bosentan therapy for pulmonary arterial hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/16142516

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of the dual endothelin receptor antagonist bosentan in patients with pulmonary arterial hypertension: a 1-year follow-up study

1 reference

https://pubmed.ncbi.nlm.nih.gov/16142516

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The endothelin antagonist bosentan inhibits the canalicular bile salt export pump: a potential mechanism for hepatic adverse reactions

1 reference

https://pubmed.ncbi.nlm.nih.gov/16142516

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00392-005-0266-6

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16142516

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16142516

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46687142&oldid=2208023592"